Ahmedabad-based Zydus has initiated talks with the Department of
Biotechnology for a compassionate trial. It is also working with the
USFDA to register the drug for "compassionate use programme". The
company has already registered the drug with the Indian drug
controller for a trial approval.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-takes-a-shot-at-old-hep-c-injection/articleshow/75259425.cms
No comments:
Post a Comment